search
Back to results

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

Primary Purpose

Influenza Vaccination

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fact Only Education Message
Fact and Myth Educational Message
Fact, Myth, Why Educational Message
Control Educational Message
Sponsored by
Northwestern University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Influenza Vaccination focused on measuring education, vaccination, preventive service, Prevention & Control

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Participant must have a scheduled appointment at least 6 weeks in advance in either the GIM or Geriatrics clinics at NMFF.
  • Participant must be a patient of Northwestern Medical Faculty Foundation.
  • Participant does not intend to receive the influenza vaccine.

Exclusion Criteria:

  • Participant has a diagnosis of Alzheimer's Disease or Dementia
  • Participant has received an influenza vaccination during either the last influenza season or the current.
  • The scheduled visit is the participant's first time being seen by this doctor (appointment is to establish care in the clinic).

Sites / Locations

  • Northwestern Medical Faculty Foundation General Internal Medicine and Geriatric Clinics

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Placebo Comparator

Arm Label

Fact Only

Fact and Myth

Fact, Myth, Why

Control

Arm Description

The educational message used will contain facts only.

The educational material seen by this arm will contain facts and myths only.

The educational material seen by this arm will contain myths, facts, and refutations of the myths.

This arm will receive fact/myth educational materials originally developed and used by the CDC.

Outcomes

Primary Outcome Measures

Influenza Vaccination
The primary outcome is receipt of influenza vaccination at appointment directly following the post-test. A pre-test was completed by participants during a telephone interview that occurred approximately two weeks prior to a scheduled clinic appointment. The post-test was completed via an in-person interview by participants immediately prior to their scheduled appointment. That is, the participants met with the Research Assistant, completed the post-test, and then proceeded to see their physician for a previously scheduled office visit.

Secondary Outcome Measures

Recall Accuracy
Participants were given 8 statements about the flu/flu shot and asked to recall if they had seen the statement on the message they received via FedEx. Participants responded that statement had been "presented as a fact," "presented as a myth," "presented, but I don't recall if it was a fact or a myth," or "not presented." Participants scored 1 for each correct answer; 0 for each incorrect answer or for response "I don't recall." Recall accuracy was calculated among each message format, range for recall accuracy was 0 - 8 with 0 indicating no correct answers and 8 representing 100% accuracy. Thus units of measurement are "units on a scale" to represent participant scores out of 8 on the recall items.

Full Information

First Posted
November 6, 2009
Last Updated
August 20, 2012
Sponsor
Northwestern University
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT01009645
Brief Title
The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination
Official Title
The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Completed
Study Start Date
September 2009 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
April 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northwestern University
Collaborators
National Institute on Aging (NIA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate whether message design of educational materials increases vaccination rates among participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Influenza Vaccination
Keywords
education, vaccination, preventive service, Prevention & Control

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
125 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fact Only
Arm Type
Experimental
Arm Description
The educational message used will contain facts only.
Arm Title
Fact and Myth
Arm Type
Experimental
Arm Description
The educational material seen by this arm will contain facts and myths only.
Arm Title
Fact, Myth, Why
Arm Type
Experimental
Arm Description
The educational material seen by this arm will contain myths, facts, and refutations of the myths.
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
This arm will receive fact/myth educational materials originally developed and used by the CDC.
Intervention Type
Behavioral
Intervention Name(s)
Fact Only Education Message
Other Intervention Name(s)
Fact Only
Intervention Description
Participants randomized to this intervention will receive an educational brochure listing the facts of the influenza vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Fact and Myth Educational Message
Other Intervention Name(s)
Fact & Myth
Intervention Description
Participants randomized to this intervention will receive an educational brochure listing the facts and myths of the influenza vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Fact, Myth, Why Educational Message
Other Intervention Name(s)
Fact, Myth, Why
Intervention Description
Participants randomized to this intervention will receive an educational brochure listing the facts, myths, and refutation of the myths of the influenza vaccine.
Intervention Type
Behavioral
Intervention Name(s)
Control Educational Message
Other Intervention Name(s)
Control
Intervention Description
Participants randomized to this intervention will receive an educational brochure created and used by the CDC in a previous influenza season.
Primary Outcome Measure Information:
Title
Influenza Vaccination
Description
The primary outcome is receipt of influenza vaccination at appointment directly following the post-test. A pre-test was completed by participants during a telephone interview that occurred approximately two weeks prior to a scheduled clinic appointment. The post-test was completed via an in-person interview by participants immediately prior to their scheduled appointment. That is, the participants met with the Research Assistant, completed the post-test, and then proceeded to see their physician for a previously scheduled office visit.
Time Frame
1 week following randomization
Secondary Outcome Measure Information:
Title
Recall Accuracy
Description
Participants were given 8 statements about the flu/flu shot and asked to recall if they had seen the statement on the message they received via FedEx. Participants responded that statement had been "presented as a fact," "presented as a myth," "presented, but I don't recall if it was a fact or a myth," or "not presented." Participants scored 1 for each correct answer; 0 for each incorrect answer or for response "I don't recall." Recall accuracy was calculated among each message format, range for recall accuracy was 0 - 8 with 0 indicating no correct answers and 8 representing 100% accuracy. Thus units of measurement are "units on a scale" to represent participant scores out of 8 on the recall items.
Time Frame
1 week following receipt of message

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participant must have a scheduled appointment at least 6 weeks in advance in either the GIM or Geriatrics clinics at NMFF. Participant must be a patient of Northwestern Medical Faculty Foundation. Participant does not intend to receive the influenza vaccine. Exclusion Criteria: Participant has a diagnosis of Alzheimer's Disease or Dementia Participant has received an influenza vaccination during either the last influenza season or the current. The scheduled visit is the participant's first time being seen by this doctor (appointment is to establish care in the clinic).
Facility Information:
Facility Name
Northwestern Medical Faculty Foundation General Internal Medicine and Geriatric Clinics
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Effect of Fact Versus Myth Messages on Receipt of Influenza Vaccination

We'll reach out to this number within 24 hrs